Zimmer Biomet Holdings Inc (ZBH) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Total Assets Chart for Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc (ZBH) total assets for FY2025 were USD 23.1B, a 8.1% change from FY2024. Zimmer Biomet Holdings Inc's total assets grew from USD 606.0M in 1999 to USD 23.1B in 2025 (3710.5% over 26 years). Total assets compound annual growth rate: 5-year CAGR of -1.1%, 10-year CAGR of -1.7%, 20-year CAGR of 7.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$18.54B
Implied Share Price
$97.19
Enterprise Value
$26.06B
Revenue (TTM)
$8.51B
EBITDA
$2.56B
Profit Margin
9.48%
Trailing P/E
23.82
Forward P/E
11.47
Price/Book (MRQ)
1.46
Price/Sales (TTM)
2.18
EV/EBITDA
11.08
EV/Revenue
3.04
Dividend Yield
0.49%
Book Value
$65.73
Free Cash Flow (FY2025)
$1.47B
Free Cash Flow Yield
7.94%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.